Cytek Biosciences Inc (CTKB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	18.83% 62.14	52.29	45.60	41.46	57.48
Cost Of Revenue	18.24% 29.26	24.74	21.73	21.30	23.82
Gross Profit	19.36% 32.88	27.55	23.87	20.16	33.65
Operating Expenses	4.72% 38.48	36.74	34.49	35.13	30.67
Benefits Costs and Expenses	10.17% 66.17	60.06	52.38	52.72	47.15
Costs And Expenses	10.17% 66.17	60.06	52.38	52.72	47.15
Operating Income/Loss	39.14% -5.594	-9.192	-10.62	-14.97	2.986
Nonoperating Income/Loss	9.84% 1.563	1.423	3.849	3.709	7.337
Income/Loss From Continuing Operations Before Tax	48.11% -4.031	-7.769	-6.775	-11.27	10.32
Income Tax Expense/Benefit, Deferred	1,568% 38.58	-2.627	-2.056	-0.336	-
Income Tax Expense/Benefit	1,848% 40.05	-2.291	-1.192	0.136	0.68
Income/Loss From Continuing Operations After Tax	704.60% -44.08	-5.478	-5.583	-11.40	9.643
Net Income/Loss	704.60% -44.08	-5.478	-5.583	-11.40	9.643
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.89% 0.1416	127.55	126.93	128.34	-0.51
Diluted Average Shares	99.89% 0.1416	127.55	126.93	128.34	-0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%